Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00440_DB00784> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00440_DB00784 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00440_DB00784 label "DDI between Trimethoprim and Mefenamic acid - The strong CYP2C9 inhibitor, Mefenamic acid, may decrease the metabolism and clearance of Trimethoprim, a CYP2C9 substrate. Consider alternate therapy or monitor for changes in therapeutic and adverse effects of Trimethoprim if Mefenamic acid is initiated, discontinued or dose changed. [drugbank_resource:DB00440_DB00784]" assertion.
- drugbank_resource:DB00440_DB00784 identifier "drugbank_resource:DB00440_DB00784" assertion.
- drugbank_resource:DB00440_DB00784 title "DDI between Trimethoprim and Mefenamic acid - The strong CYP2C9 inhibitor, Mefenamic acid, may decrease the metabolism and clearance of Trimethoprim, a CYP2C9 substrate. Consider alternate therapy or monitor for changes in therapeutic and adverse effects of Trimethoprim if Mefenamic acid is initiated, discontinued or dose changed." assertion.